Reports of patients with axillary adenopathy identified on breast imaging after coronavirus
disease (COVID-19) vaccination are rising. We propose a pragmatic management approach …

The purpose of this article is to report on 23 women with evidence of axillary adenopathy at
breast imaging after recent COVID-19 vaccination. A total of 13% of patients had symptoms …

Methods| Retrospective analysis was carried out assessing patients who received at least 1
injection of COVID-19 vaccine fewer than 90 days prior to either screening or diagnostic …

Unilateral axillary lymphadenopathy is a frequent mild side effect of COVID-19 vaccination.
European Society of Breast Imaging (EUSOBI) proposes ten recommendations to …

Axillary Adenopathy after COVID-19 Vaccine: No Reason to Delay Screening Mammogram |
Radiology RSNA "skipMainNavigation" closeDrawerMenuopenDrawerMenu Home Journals All …

With the recent US Food and Drug Administration (FDA)-approval and rollout of the Pfizer-
BioNTech and Moderna COVID-19 vaccines, it is important for radiologists to consider …

Please see the Editorial Comment by Hannah Perry discussing this article. To listen to the
podcast associated with this article, please select one of the following: iTunes, Google Play …

Introduction: Following vaccination of Israeli population with Pfizer-BioNTech COVID-19
Vaccine, an unusual increase in axillary-lymphadenopathy was noted. This study assesses …

Early clinical experience with COVID-19 vaccination suggests that approved COVID-19
vaccines cause a notably higher incidence of axillary lymphadenopathy on breast MRI …

Axillary adenopathy in women with an otherwise normal screening mammogram is a rare
occurrence, reported in 0.02%-0.04% of screening mammograms.(1-4) Reported …